Imagine you are an analyst covering the pharmaceutical sector. You are currently deep in the weeds of a valuation model for a large-cap company, while your colleague in the investment banking division is simultaneously advising that same company on a confidential acquisition. If you sit at your desk and chat about the target company’s prospects, you are inadvertently crossing a regulatory threshold that could lead to severe penalties for both you and your firm.
This is why the ‘Chinese Wall’—a functional and physical barrier between your research department and other units like corporate finance or trading—is not just a suggestion; it is a mandatory operational requirement under SEBI regulations.
The Chinese Wall ensures that Unpublished Price Sensitive Information (UPSI) does not flow from departments handling confidential mandates into your research output. If you are not part of the ‘deal team’ handling a specific transaction, you simply do not have a ’need-to-know.’ This principle mandates that information access must be restricted solely to those who require it to perform their official duties. By restricting the flow of information, your firm protects its ability to remain objective in its ratings and protects you from potential accusations of insider trading.
In practice, this means that even if you suspect your firm is involved in a secret transaction with a company you cover, you must not seek out that information. If you were to incorporate ‘insider tips’ from an investment banking colleague into your valuation, your recommendation would be compromised by tainted data. A professional analyst builds their thesis on publicly available data, such as annual reports, regulatory filings, and industry-wide trends.
When you encounter a situation where you believe you have received non-public information, you must immediately report it to your firm’s compliance officer and isolate yourself from that specific ticker until the information becomes public.
Ultimately, these policies protect the credibility of the entire securities ecosystem. When a retail investor reads your research report, they rely on the assumption that your buy or sell rating is based on independent analysis, not on leaked deal information from your firm’s internal boardroom. By adhering to the need-to-know principle, you ensure that your work remains a legitimate instrument of market transparency rather than a mechanism for illicit trading gain.
Your adherence to these barriers is the primary safeguard of your professional reputation and your license to practice in the Indian markets.
Nuance
Check Your Understanding
An analyst at a brokerage firm discovers that their investment banking colleagues are currently advising a firm on an upcoming merger. The analyst is not part of the deal team. Which of the following best describes the analyst’s required conduct under the ’need-to-know’ principle?
What is the primary objective of implementing a ‘Chinese Wall’ policy between the research department and the investment banking department of a brokerage house?
This is a companion read for Section 14.2 — Important regulations in Indian Securities Market from PASS Research Analyst Certification Examination by Akhilesh Gururani, available on Amazon Kindle.
Copyright © 2026 Akhilesh Gururani. All rights reserved.